Mark Farrar is a Managing Director within the Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations Practice, and leader of the Life Sciences Disputes and Investigations service line. National and international clients trust Mark to provide investigations, dispute advisory services, and compliance advisory assessments.
Mark advises clients in the U.S., Europe, and Asia on complex issues such as SEC financial accounting investigations, white collar crime, off-label allegations, bribe and kick-back schemes, Foreign Corrupt Practices Act (“FCPA”) matters, False Claims Act (“FCA”) damage calculations and defines, violations of the Stark Law and the Anti-Kickback Statute, embezzlements, pharmaceutical sales and marketing compliance, economic damages and lost profits settlement calculations and consultation, and various auditing and monitoring assessments.
Mark has served as an Independent Review Organization expert and as an advisor on state and federal healthcare compliance issues. He also has assisted in the development of alternative methodologies to help refute multi-billion dollar claims brought forth by government agencies.
Mark is a Certified Public Accountant licensed in the State of Georgia, a Certified Fraud Examiner, and Certified in Financial Forensics. He has given numerous lectures on topics such as the red flags of fraud and compliance and fraud matters. Mark has been a guest lecturer at Emory University, University of Georgia, Georgia Institute of Technology, DePaul University, and the University of Minnesota. He has presented widely at industry conferences on topics including Aggregate Spend issues, Research and Development, and transparency issues with physicians. He is co-author of False Claims Act Case Tracker, a quarterly publication designed to keep the legal community apprised of False Claims Act cases, trends, and important legal updates.